AI eye scanner could catch glaucoma before it steals your sight
NCT ID NCT07550712
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an AI tool called VeriSee GLC that analyzes color images of the back of the eye to find signs of glaucoma. Researchers looked at 773 adults' existing eye images to see how well the AI could identify people who might have glaucoma, comparing its results to a panel of eye experts. The goal is to give doctors a reliable screening tool to catch glaucoma earlier and refer patients for a full exam.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
VeriSee GLC (AI software for analyzing eye images)
What this could lead to
If successful, this AI tool could help eye doctors quickly identify people who might have glaucoma, leading to earlier referral and treatment.
What could go wrong
This was a retrospective study using existing images, not a real-world test. The AI is meant to assist, not replace a doctor, and may not work as well in all populations or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Taiwan University Hospital
Taipei, 100, Taiwan